Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Message Testing for Tobacco-Related Corrective Statements

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier:
NCT01282008
First received: January 21, 2011
Last updated: November 11, 2014
Last verified: February 2014
  Purpose

BACKGROUND:

This document outlines the study design and procedures to be used to evaluate a series of corrective statements to augment consumer knowledge and beliefs about smoking as related to past actions of tobacco companies. The statements were ordered by a U.S. Federal Court in U.S. v. Philip Morris USA, Inc., and are intended to target potential misperceptions resultant of past marketing and promotion practices undertaken by the tobacco industry.

OBJECTIVES:

The U.S. Department of Justice has asked NCI to take the lead on developing and testing corrective statements with adult and youth audiences to ensure both message comprehension and avoidance of unintended consequences of message exposure, such as boomerang effects, smoking triggers, or knowledge gaps.

The court has identified five areas that the statements shall address:

  1. The adverse health effects of smoking;
  2. The addictiveness of smoking and nicotine;
  3. The lack of any significant health benefit from smoking low tar, light, ultra light, mild, and natural cigarettes;
  4. The tobacco industry s manipulation of cigarette design and composition to ensure optimum nicotine delivery;
  5. The adverse health effects of secondhand smoke.

ELIGIBILITY:

Message testing will be undertaken with the following audiences:

  • Current smokers (with an oversample of low socioeconomic status individuals)
  • General population nonsmokers and former smokers (with an oversample of low socioeconomic status individuals)
  • Spanish-speaking Hispanics
  • Youth age 14-17

DESIGN:

Both qualitative and quantitative methods (focus groups and post-test comparison group Web-enabled surveys) will be used to develop and test a range of corrective statements in the five areas outlined by the court.

  • Focus group participants: 48-64
  • Survey participants: 2500

Condition
Tobacco
Smoking
Communication

Study Type: Observational
Official Title: Message Testing for Tobacco-Related Corrective Statements

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 627
Study Start Date: January 2011
Detailed Description:

BACKGROUND:

This document outlines the study design and procedures to be used to evaluate a series of corrective statements to augment consumer knowledge and beliefs about smoking as related to past actions of tobacco companies. The statements were ordered by a U.S. Federal Court in U.S. v. Philip Morris USA, Inc., and are intended to target potential misperceptions resultant of past marketing and promotion practices undertaken by the tobacco industry.

OBJECTIVES:

The U.S. Department of Justice has asked NCI to take the lead on developing and testing corrective statements with adult and youth audiences to ensure both message comprehension and avoidance of unintended consequences of message exposure, such as boomerang effects, smoking triggers, or knowledge gaps.

The court has identified five areas that the statements shall address:

  1. The adverse health effects of smoking;
  2. The addictiveness of smoking and nicotine;
  3. The lack of any significant health benefit from smoking low tar, light, ultra light, mild, and natural cigarettes;
  4. The tobacco industry s manipulation of cigarette design and composition to ensure optimum nicotine delivery;
  5. The adverse health effects of secondhand smoke.

ELIGIBILITY:

Message testing will be undertaken with the following audiences:

  • Current smokers (with an oversample of low socioeconomic status individuals)
  • General population nonsmokers and former smokers (with an oversample of low socioeconomic status individuals)
  • Spanish-speaking Hispanics
  • Youth age 14-17

DESIGN:

Both qualitative and quantitative methods (focus groups and post-test comparison group Web-enabled surveys) will be used to develop and test a range of corrective statements in the five areas outlined by the court.

  • Focus group participants: 48-64
  • Survey participants: 2500
  Eligibility

Ages Eligible for Study:   14 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:
  • Youth age 14-17
  • Youth current smokers, former smokers, and never smokers
  • Youth male and female genders
  • Youth of all race/ethnicity categories, including: White, Black/African American, Asian, Hispanic/Latino, American Indian/Alaskan Native, Native Hawaiian/Pacific Islander

EXCLUSION CRITERIA:

Participants will be excluded from focus groups and survey if they work in:

  • Media
  • Advertising, market research
  • Public health or health promotion
  • An employee of the Federal Govemment who works at HHS or DoJ
  • The tobacco or alcohol industries
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01282008

Locations
United States, Maryland
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
Investigators
Principal Investigator: Kelly D Blake, D.Sc. National Cancer Institute (NCI)
  More Information

Publications:
Responsible Party: National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier: NCT01282008     History of Changes
Other Study ID Numbers: 999911067, 11-C-N067
Study First Received: January 21, 2011
Last Updated: November 11, 2014
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Online Surveys
Tobacco Corrective Statements
Message Testing
Focus Groups

ClinicalTrials.gov processed this record on November 25, 2014